SOR is a highly prevalent feature of autism spectrum disorder (ASD). SOR can be highly disruptive yet there are few treatments to deal with this discomfort. This study can validate a readily available medication to be used as a treatment for SOR.
What are the goals of the study?
The goal of the study is to examine the short-term effect of propranolol on observed sensory over-responsiveness (SOR) behaviors. The study will also look at biomarkers (heart rate, sweat response, neural activity) associated with a SOR response to characterize the effect of propranolol.
What will happen during the visit or online?
Participants will take medication at two time points and then complete an MRI and sensory games. Families are also asked to complete questionnaires as part of the study. Short cognitive assessments may be completed to confirm eligibility for the study.
How will this help families?
Participating in this study will allow families to see if propranolol is an effective intervention for SOR and can help with discomfort or distress associated with it. This study can also lead to clinical trials aimed at finding more treatments for ASD individuals with SOR.